Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosutinib in advanced breast cancer
NCT00319254Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2006
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of bosutinib in breast cancer, sponsored by Pfizer. Started May 2006; status: completed.
02
Drugs
bosutinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00319254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319254.